AgeneBio
Baltimore, US · Delaware corporation
Biotech
Founders & leadership
MG
MICHELA GALLAGHERExecutive Officer, Director
SR
SHARON ROSENZWEIG-LIPSONExecutive Officer
GW
GERALD W. MCLAUGHLINExecutive Officer, Director
RN
RONALD NORDMANNDirector
CC
CHARLES CLARVITDirector
PL
PATRICK LEPOREDirector
FB
FLOYD BLOOMDirector
Reported raises · per SEC filings
Form D private placements▶$500.1KraisedJul 2016 · 5 investors · BiotechnologyRule 506(b)
▶$500.1KraisedJul 2016 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- FLOYD BLOOMDirector
- CHARLES CLARVITDirector
- RONALD NORDMANNDirector
- PATRICK LEPOREDirector
- MICHELA GALLAGHERDirector
- GERALD W. MCLAUGHLINExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $500.1K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$400KraisedFeb 2015 · 1 investors · BiotechnologyRule 506(b)
▶$400KraisedFeb 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- RONALD NORDMANNDirector
- CHARLES CLARVITDirector
- PATRICK LEPOREDirector
- SHARON ROSENZWEIG-LIPSONExecutive Officer
- GERALD W. MCLAUGHLINExecutive Officer, Director
- FLOYD BLOOMDirector
- MICHELA GALLAGHERExecutive Officer, Director
- Offering amount
- $900K
- Amount sold
- $400K
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $1.1M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.